Ulixacaltamide

Essential tremor

Manufacturer: Praxis Precision Medicines
Regulatory submission: NDA submitted by February 2026
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy

Disease description

18 evidence topics · 21 sources